methotrexate has been researched along with Diabetes Mellitus in 27 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (11.11) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (7.41) | 29.6817 |
| 2010's | 17 (62.96) | 24.3611 |
| 2020's | 5 (18.52) | 2.80 |
| Authors | Studies |
|---|---|
| Cipriani, P; Di Muzio, C; Giacomelli, R; Iagnocco, A; Ruscitti, P; Ursini, F | 1 |
| Chan, TM; Chen, HM; Chen, JF; Cheng, TT; Hsu, CY; Lin, CY; Su, YJ; Yu, SF | 1 |
| Ji, L; Xie, W; Yang, X; Zhang, Z | 1 |
| Burmester, GR; Fleischmann, R; Genovese, MC; González-Gay, MA; Hagino, O; Iglesias-Rodriguez, M; John, GS; Mandrup-Poulsen, T; Thangavelu, K | 1 |
| Baker, JF; Cannon, G; Duryee, MJ; England, BR; George, M; Hamilton, BC; Hunter, C; Mikuls, TR; Ogdie, A; Sauer, B; Thiele, G | 1 |
| Geller, S; Kremer, N; Sprecher, E; Zeeli, T | 1 |
| Alazawi, W; Cho, W; Shetty, A; Syn, WK | 1 |
| Cerio, R | 1 |
| Aithal, GP; Dawwas, MF | 1 |
| Kirby, B; Ryan, C | 1 |
| Hakala, M; Häkkinen, A; Järvenpää, S; Kautiainen, H; Salomaa, S; Uutela, T | 1 |
| Philipsen, P; Skiveren, J; Therming, G | 1 |
| Ananthakrishnan, AN; Cagan, A; Cai, T; Churchill, S; Gainer, VS; Karlson, EW; Kohane, I; Liao, KP; Murphy, SN; Shaw, SY | 1 |
| Hashimoto, A; Matsui, T | 1 |
| Arenberger, P; Cetkovska, P; Dolezal, T; Fialova, J; Gkalpakiotis, S; Jircikova, J; Kojanova, M | 1 |
| English, JC; Hawryluk, EB; Izikson, L | 1 |
| Aikawa, K; Asano, T; Iwadate, H; Kobayashi, H; Matsuoka, T; Ohira, H; Shio, K; Suzuki, R; Watanabe, H | 1 |
| Bhatia, R; Garg, R; Gleeson, T; Lu, B; Massarotti, E; Rekedal, LR; Solomon, DH | 1 |
| Bitterman, H; Eder, L; Elias, M; Feld, J; Laor, A; Rimar, D; Rosner, I; Rozenbaum, M; Zisman, D | 1 |
| Boltuch-Sherif, J; Erlacher, L; Horvath-Mechtler, B; Kowalski-Bodzenta, J; Mustak, M | 1 |
| Menter, A; Ryan, C | 1 |
| Barthelemy, H; Beauchet, A; Begon, E; Boyé, T; Bravard, P; Chaby, G; Descamps, V; Estève, E; Girard, C; Maccari, F; Mahé, E; Maillard, H; Quiles-Tsimaratos, N; Reguiai, Z; Schmutz, JL; Sigal, ML | 1 |
| KEIDAN, SE | 1 |
| Bird, BR; Daly, PA | 1 |
| Dignass, AU; Herrlinger, K; Schölmerich, J | 1 |
| Canavese, JC | 1 |
| Boston, B; Capizzi, RL; Rosen, M | 1 |
7 review(s) available for methotrexate and Diabetes Mellitus
| Article | Year |
|---|---|
Incident diabetes associated with hydroxychloroquine, methotrexate, biologics and glucocorticoids in rheumatoid arthritis: A systematic review and meta-analysis.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Diabetes Mellitus; Glucocorticoids; Humans; Hydroxychloroquine; Incidence; Methotrexate; Risk Assessment; Tumor Necrosis Factor-alpha | 2020 |
Methotrexate Hepatotoxicity and the Impact of Nonalcoholic Fatty Liver Disease.
Topics: Antirheumatic Agents; Chemical and Drug Induced Liver Injury; Dermatologic Agents; Diabetes Mellitus; Humans; Metabolic Syndrome; Methotrexate; Non-alcoholic Fatty Liver Disease; Obesity; Risk Factors | 2017 |
Psoriasis is a systemic disease with multiple cardiovascular and metabolic comorbidities.
Topics: Acitretin; Adipokines; Alcoholism; Antibodies, Monoclonal, Humanized; Cardiovascular Diseases; Comorbidity; Cyclosporine; Dermatologic Agents; Diabetes Mellitus; Fumarates; Humans; Immunosuppressive Agents; Inflammation; Metabolic Syndrome; Methotrexate; Obesity; Psoriasis; Risk Factors; Smoking; Tumor Necrosis Factor-alpha; Ustekinumab | 2015 |
[Risk of serious infection in patients with rheumatoid arthritis].
Topics: Age Factors; Arthritis, Rheumatoid; Biological Products; Comorbidity; Diabetes Mellitus; Female; Glucocorticoids; Humans; Incidence; Infections; Lung Diseases; Male; Methotrexate; Risk; Risk Factors; Severity of Illness Index; Sex Factors; Time Factors; Tumor Necrosis Factor-alpha | 2015 |
Non-infectious granulomatous diseases of the skin and their associated systemic diseases: an evidence-based update to important clinical questions.
Topics: Antirheumatic Agents; Crohn Disease; Dermatitis; Diabetes Mellitus; Granuloma; Humans; Methotrexate; Necrobiosis Lipoidica; Neoplasms; Neutrophils; Paraproteinemias; Rheumatoid Nodule; Sarcoidosis; Xanthomatosis | 2010 |
Psoriasis and cardiovascular disorders.
Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Cardiotonic Agents; Cardiovascular Diseases; Comorbidity; Diabetes Mellitus; Humans; Inflammation; Interleukin-12 Subunit p40; Metabolic Syndrome; Methotrexate; Obesity; Psoriasis; Randomized Controlled Trials as Topic; Retrospective Studies; Risk; Smoking; Tumor Necrosis Factor-alpha; Ustekinumab | 2012 |
[Lupus erythematosus, modern aspects (author's transl)].
Topics: Antacids; Antibodies, Antinuclear; Antigen-Antibody Complex; Azathioprine; Chlorambucil; Cyclophosphamide; Cystitis; Diabetes Mellitus; DNA; Female; Herpes Zoster; Humans; Hypertension; Immunosuppression Therapy; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Male; Menopause; Methotrexate; Neutrophils; Prednisone | 1977 |
1 trial(s) available for methotrexate and Diabetes Mellitus
| Article | Year |
|---|---|
Interleukin-6 receptor blockade or TNFα inhibition for reducing glycaemia in patients with RA and diabetes: post hoc analyses of three randomised, controlled trials.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Diabetes Mellitus; Humans; Methotrexate; Prospective Studies; Receptors, Interleukin-6; Treatment Outcome; Tumor Necrosis Factor-alpha | 2020 |
19 other study(ies) available for methotrexate and Diabetes Mellitus
| Article | Year |
|---|---|
Tofacitinib may improve insulin resistance in patients with rheumatoid arthritis and diabetes, implications for disease management and precision medicine approach.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Diabetes Mellitus; Disease Management; Humans; Insulin Resistance; Methotrexate; Precision Medicine; Treatment Outcome | 2023 |
Disease-modifying anti-rheumatic drugs associated with different diabetes risks in patients with rheumatoid arthritis.
Topics: Adult; Antirheumatic Agents; Arthritis, Rheumatoid; Cohort Studies; Diabetes Mellitus; Humans; Methotrexate | 2023 |
Disease activity, cytokines, chemokines and the risk of incident diabetes in rheumatoid arthritis.
Topics: Age Factors; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; C-Reactive Protein; Chemokines; Cytokines; Diabetes Mellitus; Female; Humans; Incidence; Male; Methotrexate; Middle Aged; Proportional Hazards Models; Registries; Risk Factors; Severity of Illness Index; Sex Factors | 2021 |
Failure of initial disease control in bullous pemphigoid: a retrospective study of hospitalized patients in a single tertiary center.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Inflammatory Agents; Diabetes Mellitus; Drug Therapy, Combination; Female; Head; Hospitalization; Humans; Hypertension; Hypoglycemic Agents; Immunosuppressive Agents; Male; Metformin; Methotrexate; Middle Aged; Pemphigoid, Bullous; Prednisone; Retrospective Studies; Risk Factors; Tertiary Care Centers; Tetracycline; Treatment Failure | 2017 |
Clinical challenges faced in real-world management of moderate-to-severe psoriasis: a personal view.
Topics: Anti-Inflammatory Agents; Antirheumatic Agents; Arthritis, Psoriatic; Biological Products; Cardiovascular Diseases; Comorbidity; Diabetes Mellitus; Disease Management; Humans; Lymphoma, Non-Hodgkin; Mental Disorders; Methotrexate; Photochemotherapy; Psoriasis | 2017 |
End-stage methotrexate-related liver disease is rare and associated with features of the metabolic syndrome.
Topics: Aged; Body Mass Index; Cholangitis, Sclerosing; Diabetes Mellitus; End Stage Liver Disease; Female; Humans; Immunosuppressive Agents; Liver Diseases, Alcoholic; Liver Transplantation; Logistic Models; Male; Metabolic Syndrome; Methotrexate; Middle Aged; Non-alcoholic Fatty Liver Disease; Odds Ratio; Risk Factors; United States | 2014 |
Patients with rheumatoid arthritis have better functional and working ability but poorer general health and higher comorbidity rates today than in the late 1990s.
Topics: Adrenal Cortex Hormones; Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Biological Products; Cohort Studies; Comorbidity; Cross-Sectional Studies; Diabetes Mellitus; Employment; Female; Finland; Health Status; Humans; Hydroxychloroquine; Hyperlipidemias; Hypertension; Male; Methotrexate; Middle Aged; Neoplasms; Patient Outcome Assessment; Respiratory Tract Diseases; Sulfasalazine; Tumor Necrosis Factor-alpha | 2015 |
Patients with psoriasis have insufficient knowledge of their risk of atherothrombotic disease and metabolic syndrome.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Arthritis, Psoriatic; Atherosclerosis; Depressive Disorder; Diabetes Mellitus; Female; Health Knowledge, Attitudes, Practice; Humans; Hypertension; Immunosuppressive Agents; Male; Metabolic Syndrome; Methotrexate; Middle Aged; Obesity; Patient Education as Topic; Psoriasis; Risk Factors; Thrombosis; Young Adult | 2015 |
Diabetes and the risk of infections with immunomodulator therapy in inflammatory bowel diseases.
Topics: Adult; Diabetes Mellitus; Female; Humans; Immunologic Factors; Inflammatory Bowel Diseases; Logistic Models; Male; Methotrexate; Middle Aged; Multivariate Analysis; Odds Ratio; Risk; Risk Factors; Tumor Necrosis Factor-alpha | 2015 |
Characteristics and risk profile of psoriasis patients included in the Czech national registry BIOREP and a comparison with other registries.
Topics: Acitretin; Adult; Biological Products; Body Mass Index; Comorbidity; Coronary Disease; Cyclosporine; Czech Republic; Dermatologic Agents; Diabetes Mellitus; Female; Humans; Hyperlipidemias; Hypertension; Keratolytic Agents; Male; Methotrexate; Middle Aged; Obesity; Phototherapy; Prevalence; Psoriasis; Quality of Life; Registries; Retreatment; Retrospective Studies; Risk Factors; Severity of Illness Index | 2017 |
A case of emphysematous pyelonephritis in a patient with rheumatoid arthritis taking corticosteroid and low-dose methotrexate.
Topics: Aged; Amyloidosis; Arthritis, Rheumatoid; Diabetes Mellitus; Dose-Response Relationship, Drug; Emphysema; Female; Glucocorticoids; Humans; Immunocompromised Host; Immunosuppressive Agents; Methotrexate; Pyelonephritis; Serum Amyloid A Protein | 2010 |
Changes in glycosylated hemoglobin after initiation of hydroxychloroquine or methotrexate treatment in diabetes patients with rheumatic diseases.
Topics: Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Blood Glucose; Diabetes Mellitus; Female; Glycated Hemoglobin; Humans; Hydroxychloroquine; Insulin; Linear Models; Lupus Erythematosus, Systemic; Male; Methotrexate; Middle Aged; Retrospective Studies; Rheumatic Diseases; Treatment Outcome | 2010 |
Clinical and demographic characteristics of patients with psoriatic arthritis in northern Israel.
Topics: Antirheumatic Agents; Arthritis, Psoriatic; Clinical Chemistry Tests; Comorbidity; Cross-Sectional Studies; Demography; Diabetes Mellitus; Drug Therapy, Combination; Family Health; Female; Humans; Hyperlipidemias; Hypertension; Immunosuppressive Agents; Israel; Joints; Male; Methotrexate; Middle Aged; Retrospective Studies | 2012 |
[Autoimmune pancreatitis associated with rheumatoid arthritis: successful combination therapy with steroids and methotrexate].
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Autoimmune Diseases; Biopsy; Comorbidity; Diabetes Mellitus; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Metacarpophalangeal Joint; Methotrexate; Pancreas; Pancreatitis; Prednisolone; Treatment Outcome | 2011 |
Evaluation of risk factors for body weight increment in psoriatic patients on infliximab: a multicentre, cross-sectional study.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Comorbidity; Cross-Sectional Studies; Diabetes Mellitus; Diet; Dyslipidemias; Female; Humans; Hypertension; Immunosuppressive Agents; Infliximab; Male; Methotrexate; Middle Aged; Obesity; Psoriasis; Retrospective Studies; Risk Factors; Severity of Illness Index; Sex Factors; Smoking; Weight Gain | 2014 |
PROLONGED REMISSION IN ACUTE LEUKAEMIA.
Topics: Blood Transfusion; Bone Marrow Cells; Bone Marrow Examination; Child; Diabetes Mellitus; Glucagon; Humans; Leukemia; Mercaptopurine; Methotrexate; Prednisolone; Prognosis; Toxicology; Triamcinolone | 1964 |
Uncommon hematologic malignancies. Case 3. Parotid swelling during treatment for transformed mycosis fungoides.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cell Transformation, Neoplastic; Cyclophosphamide; Diabetes Mellitus; Doxorubicin; Humans; Hypertriglyceridemia; Insulin Resistance; Leucovorin; Lipodystrophy; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Mycosis Fungoides; Parotid Diseases; Parotid Gland; Prednisone; Skin Neoplasms; Vincristine | 2003 |
[Ulcerative colitis. Chronic active course].
Topics: Administration, Oral; Adult; Age Factors; Anti-Infective Agents; Azathioprine; Child; Chronic Disease; Ciprofloxacin; Colectomy; Colitis, Ulcerative; Controlled Clinical Trials as Topic; Diabetes Mellitus; Diagnosis, Differential; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Male; Mercaptopurine; Methotrexate; Nutritional Physiological Phenomena; Pregnancy; Recurrence; Remission Induction; Risk Factors; Time Factors | 2004 |
[Autoregulation of L-asparaginase-induced diabetes mellitus].
Topics: Adult; Asparaginase; Diabetes Mellitus; Humans; Leukemia, Lymphoid; Male; Methotrexate | 1977 |